These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17035279)

  • 21. Resident and infiltrating immune cells in the uveal tract in the early and late stages of experimental autoimmune uveoretinitis.
    Butler TL; McMenamin PG
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2195-210. PubMed ID: 8843906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental autoimmune uveitis and retinitis induced by S-antigen immunization].
    Misiuk-Hojło M; Ruiz-Moreno J; Thillaye B; de Kozak Y
    Klin Oczna; 1993; 95(3-4):101-4. PubMed ID: 8377430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral expression of rod photoreceptor arrestin induces an epitope-specific, protective response against experimental autoimmune uveoretinitis.
    McPherson SW; Roberts JP; Gregerson DS
    Curr Eye Res; 2005 Jun; 30(6):491-502. PubMed ID: 16020282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of experimental autoimmune uveoretinitis in Lewis rats with purified recombinant human retinal S-antigen fusion protein.
    Roberts AJ; Kasp E; Stanford M; Dumonde DC; Banga JP
    Eur J Immunol; 1992 Apr; 22(4):951-6. PubMed ID: 1551407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraocular cytokine quantification of experimental autoimmune uveoretinitis in rats.
    Okada AA; Sakai J; Usui M; Mizuguchi J
    Ocul Immunol Inflamm; 1998 Jun; 6(2):111-20. PubMed ID: 9689641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed onset and decreased severity of experimental autoimmune uveoretinitis in mice lacking nitric oxide synthase type 2.
    Thillaye-Goldenberg B; Goureau O; Naud MC; de Kozak Y
    J Neuroimmunol; 2000 Oct; 110(1-2):31-44. PubMed ID: 11024532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate.
    Sakai T; Kohno H; Ishihara T; Higaki M; Saito S; Matsushima M; Mizushima Y; Kitahara K
    Exp Eye Res; 2006 Apr; 82(4):657-63. PubMed ID: 16360654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caffeic acid phenethyl ester lessens disease symptoms in an experimental autoimmune uveoretinitis mouse model.
    Choi JH; Roh KH; Oh H; Park SJ; Ha SM; Kang MS; Lee JH; Jung SY; Song H; Yang JW; Park S
    Exp Eye Res; 2015 May; 134():53-62. PubMed ID: 25795054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High mobility group box protein-1 in experimental autoimmune uveoretinitis.
    Watanabe T; Keino H; Sato Y; Kudo A; Kawakami H; Okada AA
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2283-90. PubMed ID: 19151394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematopoietically derived retinal perivascular microglia initiate uveoretinitis in experimental autoimmune uveitis.
    Gullapalli VK; Zhang J; Pararajasegaram G; Rao NA
    Graefes Arch Clin Exp Ophthalmol; 2000 Apr; 238(4):319-25. PubMed ID: 10853931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis.
    Haq E; Rohrer B; Nath N; Crosson CE; Singh I
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):221-31. PubMed ID: 17593005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resident and infiltrating cells in the rat iris during the early stages of experimental melanin protein-induced uveitis (EMIU).
    McMenamin PG; Crewe J; Kijlstra A
    Ocul Immunol Inflamm; 1997 Dec; 5(4):223-33. PubMed ID: 9455739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin.
    Kohno H; Sakai T; Saito S; Okano K; Kitahara K
    Exp Eye Res; 2007 Mar; 84(3):569-76. PubMed ID: 17208229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Participation of sodium iodate in the induction of experimental autoimmune uveoretinitis (EAU)].
    Tanaka T
    Nippon Ganka Gakkai Zasshi; 1991 Nov; 95(11):1077-84. PubMed ID: 1759647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of intravitreal administration of tresperimus, an immunosuppressive drug, on experimental autoimmune uveoretinitis.
    Bousquet E; Camelo S; Leroux les Jardins G; Goldenberg B; Naud MC; Besson-Lescure B; Lebreton L; Annat J; Behar-Cohen F; de Kozak Y
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5414-23. PubMed ID: 21666239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraocular trafficking of lymphocytes in locally induced experimental autoimmune uveoretinitis (EAU).
    Kim MK; Caspi RR; Nussenblatt RB; Kuwabara T; Palestine AG
    Cell Immunol; 1988 Apr; 112(2):430-6. PubMed ID: 2451572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological and immunopathological aspects of opsin-induced uveoretinitis.
    Broekhuyse RM; Kuhlmann ED; van Vugt AH; Winkens HJ
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(1):45-9. PubMed ID: 2952558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of intraocular cytokines in the suppression of experimental autoimmune uveoretinitis by type I IFN.
    Okada AA; Keino H; Suzuki J; Sakai J; Usui M; Mizuguchi J
    Int Immunol; 1998 Dec; 10(12):1917-22. PubMed ID: 9885913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of TLR4 activation in photoreceptor mitochondrial oxidative stress.
    Ko MK; Saraswathy S; Parikh JG; Rao NA
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5824-35. PubMed ID: 21666244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental autoimmune uveoretinitis (EAU)-related tissue damage and angiogenesis is reduced in CCL2⁻/⁻CX₃CR1gfp/gfp mice.
    Zhao J; Chen M; Xu H
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7572-82. PubMed ID: 25342612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.